Abstract
Solid lipid nanoparticles (SLN) are dispersions formed by nanometric particles that have high physiological stability and a matrix composed of solid lipids. Drugs encapsulated in NLS present an increase stability, such as possibility of prolonged, controlled, and specific release of drugs, and another advantages over other release systems like reduced toxicity of the components, non-use o…